NSH / Dalhousie Biobank, Canada

Certification Status: Approved
Registration Status: Completed

Objective: The QEII Biobank is a part of the Atlantic Canada Biobank Consortium (ACBC). The aim of the QEII Biobank is to collect 70% of acceptable tumor specimens from the surgical pathology workflow at the QEII health Sciences Centre.

Registered Biobank Name NSH / Dalhousie Biobank
Biobank Leader Sidney Croul
Country Canada
Email for biobank inquiries Biobank@nshealth.ca
Principal Investigator Sidney Croul, MD, FRCPC Professor, Dalhousie Dept of Pathology
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: